StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
37
Publishing Date
2023 - 12 - 05
1
2022 - 09 - 23
1
2022 - 06 - 13
1
2021 - 07 - 27
1
2021 - 07 - 23
1
2021 - 07 - 22
1
2021 - 07 - 16
1
2021 - 07 - 12
1
2021 - 07 - 09
1
2021 - 07 - 01
1
2021 - 06 - 24
1
2021 - 06 - 21
1
2021 - 06 - 16
1
2021 - 06 - 11
2
2021 - 06 - 09
2
2021 - 05 - 28
1
2021 - 05 - 24
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 05 - 05
1
2021 - 04 - 23
1
2021 - 04 - 22
2
2021 - 04 - 20
1
2021 - 04 - 16
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 12
1
2021 - 04 - 07
1
2021 - 03 - 25
1
2021 - 03 - 19
2
2021 - 03 - 11
1
Sector
Health technology
37
Tags
Approval
19
Cancer
19
Fda
5
Fda approval
2
N/a
37
Treatment
1
Entities
Abbott laboratories
1
Abbvie inc.
23
Adc therapeutics sa
13
Agios pharmaceuticals, inc.
10
Alnylam pharmaceuticals, inc.
10
Amgen inc.
23
Aveo pharmaceuticals, inc.
18
Beigene, ltd.
10
Biocryst pharmaceuticals, inc.
13
Biomarin pharmaceutical inc.
3
Blueprint medicines corporation
18
Bristol-myers squibb company
32
Clovis oncology, inc.
18
Eli lilly and company
37
Epizyme, inc.
18
Exelixis, inc.
10
Gilead sciences, inc.
14
Illumina, inc.
10
Incyte corporation
18
Karyopharm therapeutics inc.
18
Merck & company, inc.
1
Omeros corporation
13
Otonomy, inc.
13
Pfizer, inc.
24
Ptc therapeutics, inc.
1
Regeneron pharmaceuticals, inc.
24
Rigel pharmaceuticals, inc.
10
Sanofi
32
Scynexis, inc.
1
Supernus pharmaceuticals, inc.
3
Verastem, inc.
10
Xeris pharmaceuticals, inc.
10
Y-mabs therapeutics, inc.
18
Symbols
A
1
ABBV
24
ABT
3
ADCT
15
ADPT
1
AGIO
10
ALNY
10
AMGN
24
AMLX
1
AMZN
1
ANIP
2
ARVL
2
AVEO
20
AYTU
2
BCRX
13
BDX
19
BGNE
10
BIIB
1
BMRN
4
BMY
46
BPMC
19
BSX
1
BW
1
CLVS
20
CPRX
1
CYDY
1
EPZM
18
EXEL
10
FNCTF
5
GH
2
GILD
19
HLTH
1
ILMN
10
IMGN
1
INCY
18
INSP
1
IONS
2
JAZZ
1
JNJ
16
KPTI
19
LLY
37
MRK
1
NVAX
1
OMER
13
OTIC
13
PFE
31
PRGO
2
PTCT
1
REGN
26
RGNX
1
RIGL
10
SAGE
4
SCYX
1
SNY
42
SRPT
2
SUPN
11
TAK
2
VSTM
10
XERS
10
YMAB
19
Exchanges
Nasdaq
32
Nyse
37
Crawled Date
2023 - 12 - 07
1
2022 - 09 - 23
1
2022 - 06 - 13
1
2021 - 07 - 27
2
2021 - 07 - 22
1
2021 - 07 - 16
1
2021 - 07 - 13
1
2021 - 07 - 09
1
2021 - 07 - 01
1
2021 - 06 - 24
1
2021 - 06 - 22
1
2021 - 06 - 16
1
2021 - 06 - 11
2
2021 - 06 - 09
2
2021 - 05 - 28
1
2021 - 05 - 25
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 05 - 05
1
2021 - 04 - 23
1
2021 - 04 - 22
2
2021 - 04 - 20
1
2021 - 04 - 16
1
2021 - 04 - 14
1
2021 - 04 - 13
2
2021 - 04 - 07
1
2021 - 03 - 25
1
2021 - 03 - 19
2
2021 - 03 - 11
1
Crawled Time
00:00
4
00:01
1
10:51
1
11:36
1
12:34
1
13:07
1
13:13
1
13:17
1
13:27
1
13:50
1
14:03
1
14:30
1
14:58
1
15:49
1
17:07
1
17:37
1
17:43
1
18:04
1
18:17
2
18:26
1
18:31
2
18:32
1
18:33
1
18:40
1
18:42
1
19:11
1
19:32
1
19:47
1
19:52
1
20:00
2
20:59
1
Source
brightmindsbio.com
1
investor.alkermes.com
2
investor.aveooncology.com
2
ir.cyclerion.com
1
ir.pulmatrix.com
1
ir.vaccinex.com
1
www.aspenpharma.com
2
www.biospace.com
589
www.brickellbio.com
2
www.chi-med.com
1
www.clarivate.com
1
www.concertpharma.com
1
www.cowen.com
1
www.emmis.com
1
www.fda.gov
37
www.firstbankonline.com
1
www.globenewswire.com
200
www.hutch-med.com
2
www.precisionbiosciences.com
2
www.preludetx.com
1
www.prnewswire.com
858
www.thermogenesis.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
LLY
source :
Www.fda.gov
save search
FDA Roundup: December 5, 2023
Published:
2023-12-05
(Crawled : 14:30)
- fda.gov
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
28.11%
|
O:
0.99%
H:
0.0%
C:
0.0%
fda
FDA Roundup: September 23, 2022
Published:
2022-09-23
(Crawled : 20:00)
- fda.gov
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
Email alert
Add to watchlist
fda
FDA Approves First Systemic Treatment for Alopecia Areata
Published:
2022-06-13
(Crawled : 20:00)
- fda.gov
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
156.97%
|
O:
-0.49%
H:
0.98%
C:
0.56%
treatment
fda
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-27
(Crawled : 14:58)
- fda.gov
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
207.04%
|
O:
0.21%
H:
0.14%
C:
-0.05%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-28.7%
|
O:
-0.64%
H:
0.68%
C:
0.34%
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
-78.9%
|
O:
-0.05%
H:
1.0%
C:
-2.76%
YMAB
|
$15.09
-0.33%
-0.33%
450K
|
Health Technology
|
-53.74%
|
O:
-0.67%
H:
2.09%
C:
-0.18%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-11.16%
|
O:
-0.54%
H:
0.65%
C:
0.49%
REGN
|
$901.27
0.8%
0.78%
470K
|
Health Technology
|
54.75%
|
O:
-1.6%
H:
2.25%
C:
2.2%
KPTI
|
$1.375
25.0%
20.0%
3.1M
|
Health Technology
|
-87.13%
|
O:
-0.47%
H:
1.53%
C:
-0.35%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-31.16%
|
O:
-0.41%
H:
0.14%
C:
-0.84%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-77.83%
|
O:
2.34%
H:
0.37%
C:
-1.69%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.19%
|
O:
-0.21%
H:
4.42%
C:
2.74%
BPMC
|
$88.395
2.68%
2.61%
730K
|
Health Technology
|
5.08%
|
O:
-0.12%
H:
0.58%
C:
-0.16%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
191.17%
|
O:
-1.17%
H:
2.55%
C:
0.59%
cancer
approval
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-07-23
(Crawled : 00:00)
- fda.gov
XERS
|
$1.79
-0.56%
-0.56%
1.5M
|
Health Technology
|
Email alert
Add to watchlist
BCRX
|
$4.59
-0.43%
-0.44%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
Email alert
Add to watchlist
OMER
|
$3.32
-3.21%
-3.31%
270K
|
Health Technology
|
Email alert
Add to watchlist
SCYX
|
$1.42
0.71%
0.7%
130K
|
Health Technology
|
Email alert
Add to watchlist
OTIC
|
$0.077
|
Health Technology
|
Email alert
Add to watchlist
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-22
(Crawled : 11:36)
- fda.gov
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
214.7%
|
O:
-0.0%
H:
1.02%
C:
0.51%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-28.14%
|
O:
-0.03%
H:
1.28%
C:
1.22%
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
-80.28%
|
O:
0.18%
H:
0.31%
C:
-2.26%
YMAB
|
$15.09
-0.33%
-0.33%
450K
|
Health Technology
|
-56.8%
|
O:
-1.57%
H:
3.71%
C:
0.43%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-10.93%
|
O:
0.45%
H:
0.12%
C:
-0.6%
REGN
|
$901.27
0.8%
0.78%
470K
|
Health Technology
|
53.18%
|
O:
-0.36%
H:
1.56%
C:
0.9%
KPTI
|
$1.375
25.0%
20.0%
3.1M
|
Health Technology
|
-88.25%
|
O:
-0.53%
H:
0.38%
C:
-3.01%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-32.75%
|
O:
-0.39%
H:
0.11%
C:
-0.27%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-80.03%
|
O:
-1.49%
H:
2.0%
C:
-2.34%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.35%
|
O:
0.0%
H:
0.58%
C:
-3.46%
BPMC
|
$88.395
2.68%
2.61%
730K
|
Health Technology
|
0.57%
|
O:
-0.84%
H:
1.72%
C:
0.61%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
176.66%
|
O:
2.21%
H:
0.0%
C:
-4.87%
cancer
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-16
(Crawled : 19:11)
- fda.gov
REGN
|
$901.27
0.8%
0.78%
470K
|
Health Technology
|
Email alert
Add to watchlist
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
KPTI
|
$1.375
25.0%
20.0%
3.1M
|
Health Technology
|
Email alert
Add to watchlist
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
YMAB
|
$15.09
-0.33%
-0.33%
450K
|
Health Technology
|
Email alert
Add to watchlist
BPMC
|
$88.395
2.68%
2.61%
730K
|
Health Technology
|
Email alert
Add to watchlist
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
Email alert
Add to watchlist
cancer
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-12
(Crawled : 00:01)
- fda.gov
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
214.43%
|
O:
-0.98%
H:
1.2%
C:
0.36%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-28.14%
|
O:
-0.15%
H:
1.19%
C:
0.66%
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
-81.85%
|
O:
-0.41%
H:
2.22%
C:
-1.07%
YMAB
|
$15.09
-0.33%
-0.33%
450K
|
Health Technology
|
-54.04%
|
O:
0.03%
H:
1.08%
C:
-0.36%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-11.24%
|
O:
1.84%
H:
0.27%
C:
-0.38%
REGN
|
$901.27
0.8%
0.78%
470K
|
Health Technology
|
54.06%
|
O:
-0.08%
H:
1.11%
C:
-1.02%
KPTI
|
$1.375
25.0%
20.0%
3.1M
|
Health Technology
|
-89.07%
|
O:
0.1%
H:
1.48%
C:
-3.38%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-35.13%
|
O:
0.0%
H:
0.49%
C:
-1.05%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-80.98%
|
O:
-0.26%
H:
1.09%
C:
-0.52%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.41%
|
O:
5.35%
H:
0.7%
C:
-7.18%
BPMC
|
$88.395
2.68%
2.61%
730K
|
Health Technology
|
0.14%
|
O:
-0.21%
H:
0.05%
C:
-2.51%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
144.62%
|
O:
1.47%
H:
0.0%
C:
-5.79%
cancer
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-09
(Crawled : 18:17)
- fda.gov
REGN
|
$901.27
0.8%
0.78%
470K
|
Health Technology
|
Email alert
Add to watchlist
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
Email alert
Add to watchlist
KPTI
|
$1.375
25.0%
20.0%
3.1M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
Email alert
Add to watchlist
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
YMAB
|
$15.09
-0.33%
-0.33%
450K
|
Health Technology
|
Email alert
Add to watchlist
BPMC
|
$88.395
2.68%
2.61%
730K
|
Health Technology
|
Email alert
Add to watchlist
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
cancer
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-01
(Crawled : 13:13)
- fda.gov
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
225.35%
|
O:
-0.0%
H:
0.87%
C:
0.71%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-27.78%
|
O:
-0.6%
H:
0.48%
C:
0.21%
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
-81.77%
|
O:
-0.45%
H:
2.35%
C:
1.86%
YMAB
|
$15.09
-0.33%
-0.33%
450K
|
Health Technology
|
-55.21%
|
O:
0.24%
H:
3.9%
C:
3.69%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-12.89%
|
O:
-0.27%
H:
0.36%
C:
0.08%
REGN
|
$901.27
0.8%
0.78%
470K
|
Health Technology
|
60.09%
|
O:
-0.35%
H:
3.65%
C:
3.24%
KPTI
|
$1.375
25.0%
20.0%
3.1M
|
Health Technology
|
-89.34%
|
O:
0.0%
H:
3.0%
C:
3.0%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-36.74%
|
O:
-0.05%
H:
0.49%
C:
-0.08%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-82.31%
|
O:
0.84%
H:
1.67%
C:
0.95%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.52%
|
O:
0.0%
H:
1.9%
C:
0.0%
BPMC
|
$88.395
2.68%
2.61%
730K
|
Health Technology
|
-2.13%
|
O:
0.0%
H:
0.67%
C:
-0.34%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
127.54%
|
O:
1.21%
H:
0.0%
C:
-5.55%
cancer
approval
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-24
(Crawled : 14:03)
- fda.gov
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-34.21%
|
O:
0.23%
H:
0.52%
C:
0.13%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
243.96%
|
O:
8.21%
H:
1.89%
C:
-0.83%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-26.05%
|
O:
0.31%
H:
1.15%
C:
0.6%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
42.58%
|
O:
0.37%
H:
1.55%
C:
0.28%
XERS
|
$1.79
-0.56%
-0.56%
1.5M
|
Health Technology
|
-53.85%
|
O:
0.0%
H:
10.77%
C:
10.77%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-11.92%
|
O:
0.29%
H:
0.8%
C:
0.17%
OTIC
|
$0.077
|
Health Technology
|
-96.56%
|
O:
-0.89%
H:
3.14%
C:
1.35%
OMER
|
$3.32
-3.21%
-3.31%
270K
|
Health Technology
|
-77.8%
|
O:
0.32%
H:
0.87%
C:
0.26%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
0.99%
|
O:
0.18%
H:
2.2%
C:
0.61%
BCRX
|
$4.59
-0.43%
-0.44%
4.1M
|
Health Technology
|
-72.87%
|
O:
0.06%
H:
0.35%
C:
0.0%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
11.68%
|
O:
0.71%
H:
1.09%
C:
0.22%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-21
(Crawled : 00:00)
- fda.gov
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-33.81%
|
O:
0.18%
H:
1.54%
C:
1.39%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
241.68%
|
O:
0.25%
H:
2.13%
C:
1.63%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-27.4%
|
O:
0.21%
H:
0.83%
C:
0.33%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
43.69%
|
O:
0.5%
H:
1.37%
C:
0.91%
XERS
|
$1.79
-0.56%
-0.56%
1.5M
|
Health Technology
|
-56.2%
|
O:
0.24%
H:
0.73%
C:
-4.13%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-13.22%
|
O:
-0.32%
H:
0.17%
C:
-0.13%
OTIC
|
$0.077
|
Health Technology
|
-96.58%
|
O:
0.0%
H:
3.98%
C:
-1.33%
OMER
|
$3.32
-3.21%
-3.31%
270K
|
Health Technology
|
-77.22%
|
O:
1.39%
H:
0.79%
C:
0.33%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
1.05%
|
O:
0.57%
H:
0.86%
C:
0.54%
BCRX
|
$4.59
-0.43%
-0.44%
4.1M
|
Health Technology
|
-70.99%
|
O:
0.5%
H:
4.88%
C:
4.7%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
11.7%
|
O:
0.4%
H:
0.53%
C:
0.25%
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-06-16
(Crawled : 19:52)
- fda.gov
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
238.26%
|
O:
-0.22%
H:
1.28%
C:
0.88%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-27.88%
|
O:
0.16%
H:
0.21%
C:
-0.39%
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
-80.7%
|
O:
0.0%
H:
1.87%
C:
-0.04%
YMAB
|
$15.09
-0.33%
-0.33%
450K
|
Health Technology
|
-57.69%
|
O:
0.0%
H:
5.48%
C:
5.2%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-14.13%
|
O:
-0.98%
H:
0.77%
C:
0.65%
REGN
|
$901.27
0.8%
0.78%
470K
|
Health Technology
|
70.77%
|
O:
0.08%
H:
2.77%
C:
2.29%
KPTI
|
$1.375
25.0%
20.0%
3.1M
|
Health Technology
|
-89.03%
|
O:
-0.8%
H:
6.08%
C:
5.53%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-35.97%
|
O:
-0.29%
H:
0.84%
C:
0.3%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-83.35%
|
O:
-0.45%
H:
1.02%
C:
0.23%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.54%
|
O:
1.35%
H:
5.34%
C:
1.67%
BPMC
|
$88.395
2.68%
2.61%
730K
|
Health Technology
|
0.62%
|
O:
-0.81%
H:
3.66%
C:
-1.58%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
119.55%
|
O:
-0.29%
H:
1.76%
C:
-2.5%
cancer
approval
FDA approves selpercatinib for lung and thyroid cancers with RET gene mutations or fusions
Published:
2021-06-11
(Crawled : 18:17)
- fda.gov
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
Email alert
Add to watchlist
fda
fda approval
cancer
FDA approves ramucirumab plus erlotinib for first-line metastatic NSCLC
Published:
2021-06-11
(Crawled : 17:07)
- fda.gov
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
219.75%
|
O:
-2.79%
H:
1.13%
C:
-1.29%
fda
approval
fda approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-06-09
(Crawled : 19:32)
- fda.gov
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
230.42%
|
O:
0.43%
H:
3.91%
C:
2.89%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-26.21%
|
O:
0.23%
H:
3.28%
C:
2.81%
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
-79.48%
|
O:
1.34%
H:
2.51%
C:
1.32%
YMAB
|
$15.09
-0.33%
-0.33%
450K
|
Health Technology
|
-58.38%
|
O:
-0.14%
H:
5.67%
C:
3.3%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-13.09%
|
O:
1.21%
H:
1.07%
C:
0.67%
REGN
|
$901.27
0.8%
0.78%
470K
|
Health Technology
|
71.34%
|
O:
-0.11%
H:
2.3%
C:
2.07%
KPTI
|
$1.375
25.0%
20.0%
3.1M
|
Health Technology
|
-89.02%
|
O:
0.9%
H:
4.35%
C:
4.35%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-38.26%
|
O:
0.21%
H:
1.47%
C:
1.33%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-82.64%
|
O:
0.12%
H:
1.53%
C:
0.0%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.64%
|
O:
-3.25%
H:
2.87%
C:
-2.21%
BPMC
|
$88.395
2.68%
2.61%
730K
|
Health Technology
|
3.76%
|
O:
0.04%
H:
1.73%
C:
1.34%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
106.26%
|
O:
-0.28%
H:
1.38%
C:
-0.55%
cancer
approval
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-09
(Crawled : 10:51)
- fda.gov
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-33.87%
|
O:
0.39%
H:
2.15%
C:
2.08%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
238.35%
|
O:
0.29%
H:
2.43%
C:
2.1%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-24.24%
|
O:
0.5%
H:
2.39%
C:
2.16%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
44.69%
|
O:
0.48%
H:
1.36%
C:
0.99%
XERS
|
$1.79
-0.56%
-0.56%
1.5M
|
Health Technology
|
-53.85%
|
O:
7.18%
H:
4.52%
C:
-4.07%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-11.89%
|
O:
0.88%
H:
0.74%
C:
0.5%
OTIC
|
$0.077
|
Health Technology
|
-96.75%
|
O:
-0.84%
H:
5.93%
C:
0.42%
OMER
|
$3.32
-3.21%
-3.31%
270K
|
Health Technology
|
-78.36%
|
O:
0.95%
H:
2.0%
C:
0.25%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-0.3%
|
O:
0.09%
H:
2.4%
C:
1.6%
BCRX
|
$4.59
-0.43%
-0.44%
4.1M
|
Health Technology
|
-72.95%
|
O:
0.82%
H:
2.39%
C:
-1.11%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
12.57%
|
O:
0.46%
H:
1.42%
C:
0.67%
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-05-28
(Crawled : 18:31)
- fda.gov
ALNY
|
$145.23
-1.02%
-1.03%
500K
|
Health Technology
|
Email alert
Add to watchlist
REGN
|
$901.27
0.8%
0.78%
470K
|
Health Technology
|
Email alert
Add to watchlist
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
VSTM
|
$10.82
-1.01%
-1.02%
54K
|
Health Technology
|
Email alert
Add to watchlist
EXEL
4
|
$22.875
0.24%
0.24%
2.8M
|
Health Technology
|
Email alert
Add to watchlist
YMAB
|
$15.09
-0.33%
-0.33%
450K
|
Health Technology
|
Email alert
Add to watchlist
KPTI
|
$1.375
25.0%
20.0%
3.1M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
Email alert
Add to watchlist
BGNE
S
|
$131.885
-1.62%
-1.64%
200K
|
Health Technology
|
Email alert
Add to watchlist
ILMN
|
$118.305
0.52%
0.52%
1.9M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
Email alert
Add to watchlist
BPMC
|
$88.395
2.68%
2.61%
730K
|
Health Technology
|
Email alert
Add to watchlist
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
Email alert
Add to watchlist
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
RIGL
|
$1.115
-2.19%
-2.24%
580K
|
Health Technology
|
Email alert
Add to watchlist
AGIO
|
$29.03
0.8%
0.79%
500K
|
Health Technology
|
Email alert
Add to watchlist
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
Email alert
Add to watchlist
cancer
approval
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-05-24
(Crawled : 00:00)
- fda.gov
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-35.69%
|
O:
0.33%
H:
0.15%
C:
-0.67%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
273.59%
|
O:
0.56%
H:
1.3%
C:
0.01%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-28.02%
|
O:
0.33%
H:
1.03%
C:
0.03%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
39.98%
|
O:
0.4%
H:
0.19%
C:
-0.58%
XERS
|
$1.79
-0.56%
-0.56%
1.5M
|
Health Technology
|
-48.13%
|
O:
-1.15%
H:
1.46%
C:
-4.66%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-14.77%
|
O:
0.02%
H:
0.3%
C:
-0.3%
REGN
|
$901.27
0.8%
0.78%
470K
|
Health Technology
|
76.46%
|
O:
0.6%
H:
0.0%
C:
-1.82%
OTIC
|
$0.077
|
Health Technology
|
-96.87%
|
O:
1.21%
H:
0.0%
C:
-7.2%
OMER
|
$3.32
-3.21%
-3.31%
270K
|
Health Technology
|
-76.96%
|
O:
0.94%
H:
1.4%
C:
1.06%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-2.09%
|
O:
0.51%
H:
0.2%
C:
-2.42%
BCRX
|
$4.59
-0.43%
-0.44%
4.1M
|
Health Technology
|
-66.74%
|
O:
0.43%
H:
1.44%
C:
-2.16%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
6.21%
|
O:
-0.18%
H:
1.17%
C:
-1.12%
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-05-21
(Crawled : 18:33)
- fda.gov
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-35.97%
|
O:
0.22%
H:
0.97%
C:
-0.65%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
274.25%
|
O:
0.24%
H:
0.96%
C:
-0.06%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-27.97%
|
O:
0.36%
H:
1.01%
C:
-0.28%
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
-78.32%
|
O:
2.54%
H:
0.48%
C:
-0.29%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
38.79%
|
O:
0.35%
H:
0.65%
C:
-1.19%
YMAB
|
$15.09
-0.33%
-0.33%
450K
|
Health Technology
|
-57.99%
|
O:
0.58%
H:
1.24%
C:
-1.66%
VSTM
|
$10.82
-1.01%
-1.02%
54K
|
Health Technology
|
242.63%
|
O:
0.63%
H:
2.49%
C:
-0.62%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-15.12%
|
O:
-0.43%
H:
0.2%
C:
0.02%
RIGL
|
$1.115
-2.19%
-2.24%
580K
|
Health Technology
|
-69.02%
|
O:
0.82%
H:
1.08%
C:
-1.62%
REGN
|
$901.27
0.8%
0.78%
470K
|
Health Technology
|
74.22%
|
O:
0.18%
H:
0.46%
C:
-1.44%
KPTI
|
$1.375
25.0%
20.0%
3.1M
|
Health Technology
|
-88.46%
|
O:
0.31%
H:
1.15%
C:
-1.46%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-36.27%
|
O:
0.57%
H:
0.6%
C:
-1.46%
ILMN
|
$118.305
0.52%
0.52%
1.9M
|
Health Technology
|
-70.32%
|
O:
0.33%
H:
2.2%
C:
0.21%
EXEL
4
|
$22.875
0.24%
0.24%
2.8M
|
Health Technology
|
-7.27%
|
O:
0.08%
H:
1.64%
C:
0.45%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-83.08%
|
O:
1.04%
H:
0.0%
C:
-2.62%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.37%
|
O:
0.95%
H:
1.31%
C:
-2.81%
BPMC
|
$88.395
2.68%
2.61%
730K
|
Health Technology
|
-9.79%
|
O:
1.12%
H:
0.84%
C:
-0.08%
BGNE
S
|
$131.885
-1.62%
-1.64%
200K
|
Health Technology
|
-61.05%
|
O:
0.1%
H:
1.6%
C:
0.88%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
115.45%
|
O:
1.19%
H:
1.71%
C:
-0.33%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
5.82%
|
O:
0.71%
H:
0.14%
C:
-1.06%
ALNY
|
$145.23
-1.02%
-1.03%
500K
|
Health Technology
|
4.73%
|
O:
0.38%
H:
1.01%
C:
-0.41%
AGIO
|
$29.03
0.8%
0.79%
500K
|
Health Technology
|
-49.26%
|
O:
0.86%
H:
1.27%
C:
-0.24%
cancer
approval
← Previous
1
2
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.